10 A multiparameter flow cytometry assay to monitor natural killer cell proliferation and activation in immuno-oncology clinical trials

by Sema Kurtulus, David Quinn, Jennifer Mataraza, Jennifer Tsau, Brittney Atzmiller, Tanya Mulvey, Ghanashyam Sarikonda
Published 2020-11-01

CRISPR screening identifies T cell-intrinsic regulators of CD3-bispecific antibody responses

by Ryan D. Molony, Theresa Funk, Gina Trabucco, Erik Corcoran, David Ruddy, Malini Varadarajan, GiNell Elliot, Michelle Piquet, Joni Lam, Matthew J. Meyer, Hui Qin Wang, Sema Kurtulus, Haihui Lu
Published 2022-08-01

Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors

by Kevin Conlon, Douglas G McNeel, John A Thompson, Sema Kurtulus, Rom Leidner, Thomas A Waldmann, Andrea Wang-Gillam, William D Figg, Sumati Gupta, Cristina Bergamaschi, George N Pavlakis, Antonio Valentin, Barbara K Felber, Mario Roederer, Dionysios C Watson, Cody J Peer, E Lake Potter, Nehal S Parikh, Debby Long, Lang Ho Lee, Niladri Roy Chowdhury, Florent Bender
Published 2021-11-01

Combination immunotherapy: Where do we go from here?

by Overacre, Abigail E., Kurtulus, Sema, Sznol, Mario, Pardoll, Drew M., Anderson, Ana, Vignali, Dario A. A.
Published 2015